Oct 12, 2024, 00:40
Harry Gill: One step forward to benefit patients with acute promyelocytic leukaemia
Harry Gill, Clinical Associate Professor in Haematology at HKU Medicine, shared a post on X:
” Delighted with the positive interactions with the US FDA moving the Hong Kong-invented ARSENIC TRIOXIDE ORAL SOLUTION (ARSENOL) one step forward to benefit patients with acute promyelocytic leukaemia (APL) worldwide.”
Source: Harry Gill/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 3, 2024, 04:23
Nov 3, 2024, 04:15
Nov 3, 2024, 04:13
Nov 2, 2024, 21:41
Nov 2, 2024, 21:25